Viking Therapeutics Inc. (VKTX)
Market Closed
3 Jun, 20:00
$
29. 33
+0.04
+0.14%
$
3.63B Market Cap
- P/E Ratio
- Div Yield
1,457,270 Volume
-0.92 Eps
$ 29.29
Previous Close 
Want to track VKTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viking Therapeutics Inc. (VKTX) Statistics
Valuation metrics
Market Cap 3.63B
Enterprise value 3.2B
Trailing P/E (ttm) -10.74
Forward P/E -7.58
PEG ratio -0.03
Price/Sales (ttm) -
Price/Book (mrq) 6.07
Enterprise Value/Revenue -
Enterprise Value/EBITDA -8.14
Overview
Shares outstanding 114.79M
Float 112.74M
Shares short 24.01M
% Held by insiders 0.03%
% Held by institutions 0.63%
Average volume (10 days) 2.05M
Average volume (90 days) 2.37M
Price summary
52-Week low 22.96
52-Week high 43.15
Beta 0.82
50-Day moving average 33.14
200-Day moving average 32.7
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.3%
Return on equity -0.47%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -359.64M
Diluted EPS (ttm) -3.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 705.74M
Total cash per share (mrq) 6.11
Total debt (mrq) 137K
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 9.33%
Book value per share (mrq) 5.57
Cash Flow
Cash flow statement -278.68M
Levered free cash flow (LFCF) -160.22M
